摘要
局部晚期宫颈癌的标准治疗方案目前仍存在争议,而新辅助化疗在局部晚期宫颈癌中的应用并没有在世界范围内达成共识,其临床治疗效果也不确定。多项临床试验表明术前新辅助化疗在局部晚期宫颈癌的治疗中发挥着重要作用,但我们必须明确该治疗方案的适应证和禁忌证,实施前充分考虑其利弊。术前新辅助化疗治疗局部晚期宫颈癌的疗效还有待进一步验证。
The standard treatment for locally advanced cervical carcinoma is still controversial,and the application of neoadjuvant chemotherapy has not reached consensus worldwide;moreover,its clinical therapeutic efficacy is also uncertain.A series of clinical trials have shown that preoperative neoadjuvant chemotherapy plays an important role in the treatment of locally advanced cervical carcinoma,but we should make clear the indications and contraindications of the treatment and take full consideration of the advantages and disadvantages before it is implemented.The therapeutic efficacy of preoperative neoadjuvant chemotherapy for locally advanced cervical carcinoma remains to be further verified.
作者
张师前
王稳
ZHANG Shi-qian;WANG Wen(Department of Obstetrics and Gynecology,Qilu Hospital of Shandong University,Jinan 250012,China)
出处
《中国实用妇科与产科杂志》
CAS
CSCD
北大核心
2018年第11期1199-1203,共5页
Chinese Journal of Practical Gynecology and Obstetrics
基金
山东省医药卫生科技发展计划资助项目(2017WSA04070)
关键词
宫颈肿瘤
局部晚期
新辅助化疗
手术
cervical neoplasm
locally advanced
neoadjuvant chemotherapy
surgery